- Home
- PAVS vs NRXP Comparison
PAVS vs NRXP Comparison
Compare PAVS & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- NRXP
- Stock Information
- Founded
- PAVS 2004
- NRXP 2015
- Country
- PAVS United States
- NRXP United States
- Employees
- PAVS N/A
- NRXP N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- NRXP Health Care
- Exchange
- PAVS Nasdaq
- NRXP Nasdaq
- Market Cap
- PAVS 66.3M
- NRXP 58.5M
- IPO Year
- PAVS 2019
- NRXP N/A
- Fundamental
- Price
- PAVS $0.78
- NRXP $2.81
- Analyst Decision
- PAVS
- NRXP Strong Buy
- Analyst Count
- PAVS 0
- NRXP 4
- Target Price
- PAVS N/A
- NRXP $28.50
- AVG Volume (30 Days)
- PAVS 7.2K
- NRXP 134.9K
- Earning Date
- PAVS 08-04-2025
- NRXP 08-13-2025
- Dividend Yield
- PAVS N/A
- NRXP N/A
- EPS Growth
- PAVS N/A
- NRXP N/A
- EPS
- PAVS N/A
- NRXP N/A
- Revenue
- PAVS $6,613,273.00
- NRXP N/A
- Revenue This Year
- PAVS N/A
- NRXP N/A
- Revenue Next Year
- PAVS N/A
- NRXP $230.95
- P/E Ratio
- PAVS N/A
- NRXP N/A
- Revenue Growth
- PAVS 2.50
- NRXP N/A
- 52 Week Low
- PAVS $0.32
- NRXP $1.10
- 52 Week High
- PAVS $1.50
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- PAVS 38.22
- NRXP 35.57
- Support Level
- PAVS $0.71
- NRXP $2.89
- Resistance Level
- PAVS $1.00
- NRXP $3.15
- Average True Range (ATR)
- PAVS 0.06
- NRXP 0.14
- MACD
- PAVS -0.00
- NRXP -0.04
- Stochastic Oscillator
- PAVS 23.88
- NRXP 7.27
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.